Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Adenoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Herder, WW; Feelders, RA; Krenning, EP; Kwekkeboom, DJ; Reijs, AEM; van Aken, MO; van der Lely, AJ1
de Herder, WW; Hofland, LJ; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Nobels, FR; Oei, HY; Reijs, AE1
Acampa, W; Cerbone, G; Colao, A; Ferone, D; Lastoria, S; Lombardi, G; Merola, B; Salvatore, M; Varrella, P1
de Herder, WW; de Swart, J; Kaandorp, Y; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Reijs, AE1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma

ArticleYear
Diagnostic imaging of dopamine receptors in pituitary adenomas.
    European journal of endocrinology, 2007, Volume: 156 Suppl 1

    Topics: Adenoma; Benzamides; Dopamine Antagonists; Humans; Pituitary Neoplasms; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

2007

Trials

1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma

ArticleYear
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:1

    Topics: Adenoma; Aminoquinolines; Benzamides; Biomarkers; Dopamine Agonists; Glycoprotein Hormones, alpha Subunit; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Iodine Radioisotopes; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Pyrrolidines; Tomography, Emission-Computed, Single-Photon

1998

Other Studies

2 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma

ArticleYear
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    Clinical endocrinology, 1996, Volume: 45, Issue:6

    Topics: Adenoma; Adolescent; Adult; Aminoquinolines; Benzamides; Contrast Media; Dopamine Agonists; Dopamine Antagonists; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Thyrotropin; Tomography, Emission-Computed, Single-Photon

1996
Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:1

    Topics: Adenoma; Benzamides; Brain; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1999